Literature DB >> 672618

Inhibitory effect of calcitonin on growth hormone and insulin secretion in man.

L Cantalamessa, A Catania, E Reschini, M Peracchi.   

Abstract

The effect of calcitonin administration on basal and arginine-stimulated growth hormone and insulin plasma levels was investigated. The intramuscular injection of synthetic salmon calcitonin (100 U MRC) in five normal subjects produced a significant decrease (p less than 0.05) in insulin concentration. The same amount of calcitonin given 15 min before an arginine infusion test in seven normal subjects significantly reduced the response of growth hormone (p less than 0.025) and insulin (p less than 0.005) to the stimulus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 672618     DOI: 10.1016/0026-0495(78)90143-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Synthetic salmon calcitonin is not diabetogenic in patients with normal or impaired glucose metabolism.

Authors:  G Giustina; B Cerudelli; A Cimino; C Rigosa; A Rotondi; E Radaeli
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

2.  Does calcitonin modulate anterior pituitary hormone secretion?

Authors:  G P Ceda; G Valenti; E Dall'Aglio; E Palummeri; D Provvedini; U Butturini
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

3.  Immunoreactive calcitonin in brain regions and pituitary of sheep.

Authors:  S Balabanova; O King; R Nowak; H Sachs; D Leupold
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

4.  Effect of human calcitonin (hCT) on glucose- and arginine-stimulated insulin secretion.

Authors:  S Sgambato; N Passariello; G Paolisso; A Marano; R Buoninconti; P Tesauro
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

5.  Glycoprotein hormone alpha-subunit-producing pituitary adenomas in rats treated for one year with calcitonin.

Authors:  J L Jameson; J Weiss; J M Polak; G V Childs; S R Bloom; J H Steel; C C Capen; D E Prentice; A W Fetter; J M Langloss
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

6.  Parathyroid hormone and calcitonin in glucose regulation.

Authors:  G Zamboni; A Albertini; G Zoppi; M Cecchettin
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

7.  Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome.

Authors:  A Antonelli; C Gambuzza; F Bertoni; L Baschieri
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

8.  Calcitonin and insulin secretion in normal man: study with somatostatin and calcium.

Authors:  F Caviezel; R Mangili
Journal:  Acta Diabetol Lat       Date:  1983 Jan-Mar

9.  Long- and short-term side effects and safety of calcitonin in man: a prospective study.

Authors:  S J Wimalawansa
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

Review 10.  Pharmacology and therapeutic use of calcitonin.

Authors:  J C Stevenson; I M Evans
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.